Statera BioPharma (FRA:7CB) Total Assets: €12.88 Mil (As of Sep. 2022)


FRA:7CB Statera BioPharma Inc FRA:7CB
20 GF Score
Price €2.61
View Full Analysis

What is Statera BioPharma Total Assets?

Statera BioPharma FRA:7CB 20 Total Assets is €12.88 Mil as of Sep. 2022. GuruFocus rates FRA:7CB with a GF Score™ of 20/100.

Statera BioPharma's Total Assets for the quarter that ended in Sep. 2022 was €12.88 Mil.

Total Assets is connected with ROA %. Statera BioPharma's annualized ROA % for the quarter that ended in Sep. 2022 was -105.33%. Total Assets is also linked to Revenue through Asset Turnover. Statera BioPharma's Asset Turnover for the quarter that ended in Sep. 2022 was 0.00.

Statera BioPharma  (FRA:7CB) Total Assets Explanation

Total Assets is connected with ROA %.

Statera BioPharma's annualized ROA % for the quarter that ended in Sep. 2022 is

ROA %=Net Income (Q: Sep. 2022 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Sep. 2022 ))/ count )
=-13.528/( (12.811+12.876)/ 2 )
=-13.528/12.8435
=-105.33 %

Note: The Net Income data used here is four times the quarterly (Sep. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Statera BioPharma's Asset Turnover for the quarter that ended in Sep. 2022 is

Asset Turnover
=Revenue (Q: Sep. 2022 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Sep. 2022 ))/ count )
=0/( (12.811+12.876)/ 2 )
=0/12.8435
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Statera BioPharma Total Assets Related Terms

Statera BioPharma Total Assets Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Total Assets Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Total Assets
0.00 0.85 18.74

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 83.33 18.74 12.27 12.81 12.88
FRA:7CB
20GF Score
Statera BioPharma Inc FRA:7CB
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Statera BioPharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Statera BioPharma's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=-1.334+20.068
=18.73

Statera BioPharma's Total Assets for the quarter that ended in Sep. 2022 is calculated as

Total Assets=Total Equity (Q: Sep. 2022 )+Total Liabilities (Q: Sep. 2022 )
=-10.27+23.146
=12.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €12.88 Mil mean?
Statera BioPharma (FRA:7CB) has a Total Assets of €12.88 Mil as of Sep. 2022. The total amount of assets as recorded on a company's balance sheet. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Total Assets too high?
Statera BioPharma's current Total Assets is €12.88 Mil. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Total Assets compare to NRBO and PALI?
Statera BioPharma's Total Assets of €12.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Total Assets is €12.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (FRA:7CB) has a current Total Assets of €12.88 Mil. The current Total Assets is €12.88 Mil. Statera BioPharma's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Statera BioPharma (FRA:7CB), the current Total Assets is €12.88 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
20GF Score

Get the complete analysis for FRA:7CB

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price